Associated Papers
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling.
Wilding B et al.
Nature Cancer, 2022
Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
Xu W et al.
Nature Structural & Molecular Biology, 2005
Select a paper to view details